Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists

Clinical trial NCT06640972 · COMPLETED

Trial details

NCT number: NCT06640972
Sponsor: Response Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Triglycerides Weight Gain Trajectory Cholesterol, Elevated

Start date: 2024-09-27
Primary completion: 2025-01-04
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.